Upsher-Smith relaunches Klor-Con powder

Upsher-Smith, the Maple Grove, Minn.-based subsidiary of Japan’s Sawai Pharmaceuticals, has re-introduced its Klor-Con (potassium chloride for oral solution). The company received approval from the Food and Drug Administration for the product that joins its generics portfolio. The company noted that the relaunched product would be available with a new NDC number.

The product has a U.S. market size of $98 million for the 12 months ended September 2017, according to data from IQVIA.

‘The past six months have been particularly exciting for Upsher-Smith as we have transitioned from a privately-owned company to an integral part of the Sawai Group, a globally driven, publicly traded Japanese Company," Upsher-Smith president and CEO Rusty Field said. “The ANDA approval of KLOR-CON® Powder along with other recent ANDA approvals demonstrate our commitment to expanding our portfolio of quality, high-value generic products.”